MX2021014546A - Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales. - Google Patents
Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales.Info
- Publication number
- MX2021014546A MX2021014546A MX2021014546A MX2021014546A MX2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A
- Authority
- MX
- Mexico
- Prior art keywords
- neuronal
- hydroxybutyrate
- beta
- transient ischemic
- ischemic attacks
- Prior art date
Links
- 230000001537 neural effect Effects 0.000 title abstract 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 title abstract 2
- 208000032109 Transient ischaemic attack Diseases 0.000 title abstract 2
- 239000007983 Tris buffer Substances 0.000 title abstract 2
- 201000010875 transient cerebral ischemia Diseases 0.000 title abstract 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 title 1
- -1 Glyceryl Tris Chemical compound 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000016273 neuron death Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Un método de uso del Tris (Beta-hidroxibutirato) de glicerilo en la minimización, reducción o prevención del déficit neuronal y/o muerte de células neuronales con respecto a los ataques isquémicos transitorios neuronales (NTIA) de seguimiento en sujetos que tuvieron (o en sujetos que presentan sintomatología de haber tenido) al menos un NTIA previo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2019/034592 WO2020242478A1 (en) | 2019-05-30 | 2019-05-30 | Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014546A true MX2021014546A (es) | 2022-01-06 |
Family
ID=73552030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014546A MX2021014546A (es) | 2019-05-30 | 2019-05-30 | Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220288006A1 (es) |
EP (1) | EP3976021A4 (es) |
JP (1) | JP7403861B2 (es) |
KR (1) | KR20220016145A (es) |
CN (1) | CN113710243A (es) |
BR (1) | BR112021022763A2 (es) |
CA (1) | CA3136552C (es) |
IL (1) | IL288343B2 (es) |
MX (1) | MX2021014546A (es) |
WO (1) | WO2020242478A1 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2530753T3 (es) | 1997-03-17 | 2015-03-05 | Btg Int Ltd | Composiciones terapéuticas que comprenden cuerpos cetónicos y precursores de los mismos |
GB0420856D0 (en) | 2004-09-20 | 2004-10-20 | Ketocytonyx Inc | Cns modulators |
CN104224823A (zh) * | 2007-03-30 | 2014-12-24 | 有限会社爱泽世 | 生酮作用促进剂组合物 |
MX2009011002A (es) | 2007-04-12 | 2010-03-15 | Univ Minnesota | Composiciones de proteccion de isquemia/reperfusion y metodos de uso. |
CN105640931A (zh) * | 2008-07-03 | 2016-06-08 | 艾克塞拉公司 | 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物 |
WO2017011294A1 (en) * | 2015-07-10 | 2017-01-19 | Cognate Nutritionals, Inc. | Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone esters, and other ketogenic sources |
US20180177753A1 (en) * | 2016-12-23 | 2018-06-28 | Neuroenergy Ventures, Inc. | Glyceryl 3-hydroxybutyrates for migraine symptom management |
US9925164B1 (en) * | 2017-01-12 | 2018-03-27 | Neuroenergy Ventures, Inc. | Glyceryl 3-hydroxybutyrates for traumatic brain injury |
-
2019
- 2019-05-30 IL IL288343A patent/IL288343B2/en unknown
- 2019-05-30 US US17/608,350 patent/US20220288006A1/en active Pending
- 2019-05-30 WO PCT/US2019/034592 patent/WO2020242478A1/en unknown
- 2019-05-30 JP JP2021568387A patent/JP7403861B2/ja active Active
- 2019-05-30 CN CN201980095609.2A patent/CN113710243A/zh active Pending
- 2019-05-30 CA CA3136552A patent/CA3136552C/en active Active
- 2019-05-30 KR KR1020217042604A patent/KR20220016145A/ko unknown
- 2019-05-30 EP EP19930919.6A patent/EP3976021A4/en active Pending
- 2019-05-30 BR BR112021022763A patent/BR112021022763A2/pt unknown
- 2019-05-30 MX MX2021014546A patent/MX2021014546A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3976021A1 (en) | 2022-04-06 |
CA3136552A1 (en) | 2020-12-03 |
US20220288006A1 (en) | 2022-09-15 |
IL288343B1 (en) | 2023-12-01 |
WO2020242478A1 (en) | 2020-12-03 |
KR20220016145A (ko) | 2022-02-08 |
JP2022537487A (ja) | 2022-08-26 |
IL288343B2 (en) | 2024-04-01 |
JP7403861B2 (ja) | 2023-12-25 |
EP3976021A4 (en) | 2022-11-09 |
IL288343A (en) | 2022-07-01 |
CA3136552C (en) | 2024-01-16 |
CN113710243A (zh) | 2021-11-26 |
BR112021022763A2 (pt) | 2022-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018003168A2 (es) | Moduladores de la expresión de kras | |
BR112018003102A2 (pt) | garras para dissecção cirúrgica | |
MX2022001018A (es) | Electrodos metalicos de bajo costo. | |
WO2018213661A3 (en) | PASSIVATION AGENTS FOR ELECTROCHEMICAL CELLS | |
BR112018001870A2 (pt) | fixador rosqueado. | |
DOP2021000044A (es) | Moduladores de la expresión de pnpla3 | |
BR112018074283A2 (pt) | composição e métodos para terapia com microbiota. | |
BR112018007384A2 (pt) | redução da sensação pungente na pele | |
BR112015016120A8 (pt) | dispositivo de suporte e conjuntos | |
PH12019502174A1 (en) | Modulators of pcsk9 expression | |
MY187277A (en) | Load compensator having tension spring assemblies contained in a tubular housing | |
WO2017021855A3 (en) | Motile sperm domain containing protein 2 and inflammation | |
MX2021014546A (es) | Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales. | |
PH12021551435A1 (en) | Triple combination therapies for anti-aging | |
CL2021001246A1 (es) | Moduladores de expresión irf5. | |
MX2022001898A (es) | Metodos para el tratamiento de enfermedades asociadas a la senescencia. | |
WO2016130498A8 (en) | Isolated mucins and different microorganisms, and methods of use | |
BR112018014171A2 (pt) | composições biofotônicas para o tratamento de otite externa | |
CL2020003346A1 (es) | Métodos para tratar la pérdida de la audición y/o pérdida de la visión asociadas con clrn1 | |
EP3743630A4 (en) | CORROSION RESISTANT BEARING ELEMENTS, BEARING ASSEMBLIES, BEARING UNITS, AND MOTOR ASSEMBLIES USING THESE | |
EP3692936A4 (en) | STEEL LOCKING PLATE AND STEEL LOCKING PLATE ASSEMBLY INCLUDING IT | |
BR112019023979A2 (pt) | compostos, composições e métodos | |
López | A Chicana's Look at the International Women's Year Conference | |
Okhrin et al. | Erratum to: Copulae in high dimensions: An introduction | |
Lee | Study on the Fire Safety Performance Beyond Measures of School Facilities |